The call for applications for the "Gilead Cell Therapy Grants 2027" is OPEN!
The Belgian Hematology Society (BHS), with the support of an unrestricted grant from Gilead Sciences and Kite, a Gilead company, has the pleasure to announce one grant to support research in the field of cellular therapies in hematological disease.
Researchers working in hematology are invited to submit their projects on behalf of their department and apply for the Gilead Cell Therapy Grants. All information on rules and regulations are available on the homepage, as is the application form.
The deadline for submission is on Monday, 04 January 2027, at midnight CET.
The jury will select one winning project based on their innovative character, which will be awarded with EUR 25.000. The award ceremony will take place at the 42nd BHS General Annual Meeting, March 12-13, 2027.
We are looking forward to receiving outstanding projects that can advance the outcomes of hematological diseases through cellular therapies.
Sincerely,
Ann De Becker, President of the BHS
image widget